Foghorn Therapeutics Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Foghorn Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Foghorn Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • Foghorn Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $1.99M, a 11.3% decline year-over-year.
  • Foghorn Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $4.23M.
  • Foghorn Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Foghorn Therapeutics Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.23M +$4.23M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2021-03-18
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.